Gunzburg spoke about plans to create a single flu and COVID vaccine

The Gamaleya Center will begin conducting clinical trials of a single vaccine against influenza and CORONAVIRUS at the end of 2022. This was announced to Izvestia by the DIRECTOR of the center Alexander Gintsburg.

According to him, a hybrid vaccine against rotaviruses was taken as the basis of the new drug, in parallel with it, the development of a drug against various variants of coronavirus is underway.

“The technological platform for this has already been created, but clinical trials have not yet begun. If everything goes well with this platform, this particular technology will work, then we will move on to a more complex option - combining influenza hemagglutinin antigens and, accordingly, coronavirus S-proteins in one vaccine. The start of clinical trials of a new drug is the end of next year,” Gunzburg said.

In RUSSIA, they began to study the unified use of vaccines against covid and influenza Society

In September, the Russian Ministry of HEALTH announced the start of studies on the simultaneous use of influenza and coronavirus vaccines. At the briefing, the HEAD of the department, Mikhail Murashko, spoke about the start of preclinical studies of such a combination of drugs in animals. “Based on the results, decisions will be made on further steps,” the minister said. The Ministry of Health, in turn, said that with successful trials, the combination of flu and covid-19 vaccination will help to avoid the overlap of diseases. “This is especially true in the autumn-winter period, when there is an increased incidence,” the ministry added.

The fact that studies of the compatibility of vaccines against influenza and coronavirus will be carried out in Russia “as soon as possible”, said Deputy Health Minister Oleg Gridnev earlier. Prior to that, in early September, the head of the Ministry of Industry and Trade, Denis Manturov, said that the first results of a study of a combined Russian vaccine against coronavirus and influenza could appear by the end of 2021.

So far, five vaccines against COVID-19 have been registered in Russia. These are Sputnik V and Sputnik Light, created by the Moscow Center. Gamaleya, "EpiVakKorona" and "EpiVakKorona-N" from the Novosibirsk center "Vector", as well as developed at the Center. Chumakov drug "KoviVak".

Over the previous day, 25,133 new cases of COVID-19 infection were detected in Russia, another 929 people died - this is a new record for daily mortality in Russia. The previous record was set on October 5, when 895 people were declared dead from the coronavirus.

How the number of deaths from Covid-19 in Russia is changing 6 October Daily data from the operational headquarters Created with Highcharts 8.2.2RussiaMoscowSt.
Jan 2020
2021Oct.02004006008001000 Source: federal and regional headquarters for the fight against coronavirus Data for Russia i
 

Okko and RBC.The best video"Survivors": a new post-apocalyptic series."Cruella": a spinoff about the villain,conquering the world of fashion"Mauritanian":New with Benedict CumberbatchMovie Collection: Black Mirror StyleBlack mirror styleBlack mirror style